Gts Securities LLC Amicus Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$9.55 - $12.09 $249,255 - $315,549	26,100 Added 248.57%	36,600 $390,000
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $35,256 - $45,825	-3,900 Reduced 27.08%	10,500 $104,000
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $430,911 - $536,848	-37,700 Reduced 72.36%	14,400 $169,000
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $376,866 - $548,856	37,800 Added 264.34%	52,100 $739,000
Q3 2023 Nov 15, 2023	BUY	$11.78 - $13.86 $168,454 - $198,198	14,300 New	14,300 $173,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.79B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.